AxoGen, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDAxoGen, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings contraction of 348% provides fundamental context to the price action. However, price is extended 27% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $38.49 | +12.96% | ABOVE |
| 50 SMA | $34.36 | +26.53% | ABOVE |
| 100 SMA | $33.63 | +29.28% | ABOVE |
| 150 SMA | $29.95 | +45.17% | ABOVE |
| 200 SMA | $26.30 | +65.33% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AXGN in an uptrend right now?
AXGN has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, AXGN is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is AXGN overbought or oversold?
AXGN's RSI (14) is 72. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is AXGN outperforming the market?
AXGN has a Relative Strength (RS) Rating of 94 out of 99. Yes, AXGN is a market leader, outperforming 94% of all stocks over the past 12 months.
Where is AXGN in its 52-week range?
AXGN is trading at $43.48, which is 95% of its 52-week high ($45.75) and 94% above its 52-week low ($9.22).
How volatile is AXGN?
AXGN has a Beta of 0.90 and 52-week volatility of 61%. It's less volatile than the S&P 500 - generally more stable.